CLINIC-BASED BUPRENORPHINE TREATMENT: Evidence-Based for Retention in HIV Care
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

CLINIC-BASED BUPRENORPHINE TREATMENT: Evidence-Based for Retention in HIV Care

  • 03/10/2017

Filetype[PDF-628.18 KB]



Details:

  • Description:
    Clinic-based Buprenorphine Treatment integrates buprenorphine-naloxone (BUP) treatment into HIV primary care. After a 2-day BUP induction, opioid-dependent HIV clinic patients receive BUP doses in the HIV clinic 3 times weekly for 2 to 4 weeks until they are stabilized. At each clinic visit, patients also receive unstructured individual counseling, provide urine samples for point-of-care urine drug tests, take BUP doses under observation, and receive take-home supplies of BUP to last until their next clinic visit. A treatment team of the interventionist and BUP-prescribing physicians meets weekly to discuss patients’ progress in treatment.
  • Document Type:
  • CIO:
  • Division:
  • Topic:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov